Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About Infertility Services
Infertility is the failure to achieve pregnancy after 12 months of unprotected intercourse. Infertility occurs due to the abnormal functioning of the female and male reproductive system. It can be treated with infertility drugs and through procedures such as artificial insemination, in-vitro fertilization, and surrogacy.
Technavio’s analysts forecast the infertility services market in US to grow at a CAGR of 4.65% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the infertility services market in US for 2017-2021. To calculate the market size, the report considers the services carried out during treatment via infertility drugs and assisted reproductive technology (ART) services.
Technavio's report, Infertility Services Market in US 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• CARE facility
• CooperSurgical
• Ferring Pharmaceuticals
• Monash IVF
• Merck
• Vitrolife
Other prominent vendors
• AbbVie
• Apricus Biosciences
• AstraZeneca
• Auxogyn
• Eli Lilly
• EMD Serono
• IKS International
• InVitro Care
• INVO Bioscience
• Irvine Scientific
• LifeGlobal
• MedITEX
• NMC Health
• OB GYN Associates
• OvaScience
• Pantec Biosolutions
• Reproductive Medicine Associates of New Jersey
• The Sims Clinic
• TriHealth
• Virtus Health
• Xytex Cryo International
Market driver
• Rising success rate of infertility treatments.
• For a full, detailed list, view our report
Market challenge
• Limited reimbursements and lack of strict regulatory oversight.
• For a full, detailed list, view our report
Market trend
• Upsurge in mergers and acquisitions.
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Infertility is the failure to achieve pregnancy after 12 months of unprotected intercourse. Infertility occurs due to the abnormal functioning of the female and male reproductive system. It can be treated with infertility drugs and through procedures such as artificial insemination, in-vitro fertilization, and surrogacy.
Technavio’s analysts forecast the infertility services market in US to grow at a CAGR of 4.65% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the infertility services market in US for 2017-2021. To calculate the market size, the report considers the services carried out during treatment via infertility drugs and assisted reproductive technology (ART) services.
Technavio's report, Infertility Services Market in US 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• CARE facility
• CooperSurgical
• Ferring Pharmaceuticals
• Monash IVF
• Merck
• Vitrolife
Other prominent vendors
• AbbVie
• Apricus Biosciences
• AstraZeneca
• Auxogyn
• Eli Lilly
• EMD Serono
• IKS International
• InVitro Care
• INVO Bioscience
• Irvine Scientific
• LifeGlobal
• MedITEX
• NMC Health
• OB GYN Associates
• OvaScience
• Pantec Biosolutions
• Reproductive Medicine Associates of New Jersey
• The Sims Clinic
• TriHealth
• Virtus Health
• Xytex Cryo International
Market driver
• Rising success rate of infertility treatments.
• For a full, detailed list, view our report
Market challenge
• Limited reimbursements and lack of strict regulatory oversight.
• For a full, detailed list, view our report
Market trend
• Upsurge in mergers and acquisitions.
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
